-
GlaxoSmithKline * 2,000,000,000 Jul-12
-
Pfizer * 1,000,000,000 Sep-09
-
Abbott * 800,000,000 May-12
-
Merck 650,000,000 Jan-08
-
Merck * 628,000,000 Nov-11
-
GlaxoSmithKilne * 600,000,000 Oct-10
-
TAP Pharmaceuticals 559,483,560 Oct-01
-
Astra Zeneca 520,000,000 Apr-10
-
Eli Lilly 438,000,000 Jan-09
-
Abbott Labs * 400,000,000 Jul-03
-
Bristol-Myers Squibb 328,000,000 Sep-08
-
Northrop-Grumman 325,000,000 Apr-03
-
HealthSouth * 325,000,000 Dec-04
-
AstraZeneca * 266,127,844 Jun-03
-
St. Barnabas Hospitals 265,000,000
-
Jun-06 Bayer Corp. * 257,200,000 Apr-03
-
Quest Diagnostics 241,000,000 May-11
-
Aventis Pharmaceuticals 180,000,000 Sep-07
-
Johnson & Johnson 158,000,000 Feb-12
-
Par Pharmaceutical 154,000.00 Sep-11
-
Pfizer/Warner-Lambert * 152,000,000 May-04
-
Medco 150,000,000 Oct-08
-
GlaxoSmithKline 150,000,000 Sep-08
-
Wellcare 137.500,000 Apr-12
-
Caremark 137,500,000 Sep-08
-
King Pharmaceutical 124,000,000 Nov-08
-
National Health Labs 100,000,000 Dec-92
-
GlaxoSmithKline 87,600,922 Apr-08
-
Depuy Orthopaedics 84,700,000 Sep-08
-
Watson Pharmaceuticals 79,000,000 Sep-11
-
Kyphon/Medtronics 75,000,000 May-08
-
Beth Israel Hospital 72,000,000 Dec-08
-
Novartis / Sandoz 66,000,000 Sep-11
-
Cox Health 60,000,000 Jul-08
-
General Electric * 59,500,000 Jul-93
-
Gambro Healthcare Inc. 53,100,000 Jul-00